🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
JNJ
NYSE
🇺🇸 US
Johnson & Johnson
Healthcare
14Score
DipBuster Score™
$265.95
+$2.55 (+0%)
Live price · Source: FMP-live
52-Week Position
$164.23
97% of range
$269.43
Dividend
—
no income
Mkt Cap
$640.20B
total value
Mkt Cap$640.20B
P/EN/A
DividendNone
BetaN/A
52W High$269.43
52W Low$164.23
DipBuster Brief
Key signals at a glance
Zone: Sell / Avoid
Bearish
Near 52-Week High — Asymmetric Risk
At 97% of its annual range the stock is close to its peak. New buyers face limited upside and meaningful downside if sentiment shifts.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt Cap$640.20B
52W Position97% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Johnson & Johnson (JNJ), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-07-20 | Broadhurst Vanessa | SELL | 11,925 |
| 2026-07-20 | Broadhurst Vanessa | SELL | 11,129 |
| 2026-07-20 | Broadhurst Vanessa | SELL | 23,054 |
| 2026-07-20 | Broadhurst Vanessa | BUY | 11,925 |
| 2026-07-20 | Broadhurst Vanessa | BUY | 11,129 |
| 2026-06-11 | Wengel Kathryn E | SELL | 10,000 |
| 2026-06-11 | Wengel Kathryn E | SELL | 10,000 |
| 2026-06-11 | Wengel Kathryn E | BUY | 10,000 |
| 2026-06-09 | Woods Eugene A. | BUY | 161 |
| 2026-06-09 | Pinto Daniel E | BUY | 134 |
Valuation
P/E RatioN/A
Market Cap$640.20B
BetaN/A
Dividend/yrNone
52W High$269.43
52W Low$164.23
52-Week Range
$164.23Now$269.43
97% through annual range
From 52W High−1.3%
From 52W Low+61.9%
📖 Plain English Summary
Johnson & Johnson is at 97% of its 52-week range.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for JNJ
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — JNJ
Heuristic · balance sheet, insider filings, price data, academic research
Johnson & Johnson — DipBuster Score 14/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Johnson & Johnson free
Add JNJ to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
1/25
Momentum & Volume
8/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
0
/100 · NEUTRAL
dip depth
0/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Insiders' avg buy price: $206.15 — marked 🟡 on the chart above.
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 14/100
📊
Run a full check in the AI analysis tab for a deeper look.